Table 2. Tumour and clinical characteristics of patients by cancer site.

Variable	Breast		Colorectal		Lung		Prostate
	Freq.	%	Freq.	%	Freq.	%	Freq.	%
Symptoms at first presentation
Alert	8,150	94.3	2,178	36.8	533	9.3	357	20.2
Non-alert	489	5.7	3,734	63.2	5,204	90.7	1,406	79.8
Tumour differentiation
Well differentiated	1,090	12.6	284	4.8	109	1.9	73	4.1
moderately differentiated	3,418	39.6	3,643	61.6	520	9.1	304	17.2
poorly- or undifferentiated	3,018	34.9	837	14.2	1,269	22.1	241	13.7
unknown	1,113	12.9	1,148	19.4	3,839	66.9	1,145	64.9
Comorbidity
0	7,818	90.5	5,053	85.5	4,467	77.9	1,473	83.6
1	600	6.9	616	10.4	974	17.0	206	11.7
2 or more	221	2.6	243	4.1	296	5.2	84	4.8
Surgery
no	1,086	12.6	1,096	18.5	3,610	62.9	923	52.4
yes	7,288	84.4	4,552	77.0	1,343	23.4	635	36.0
unknown	265	3.1	264	4.5	784	13.7	205	11.6
Radiotherapy
no	4,843	56.1	4,084	69.1	3,128	54.5	1,241	70.4
yes	2,849	33.0	895	15.1	2,028	35.3	275	15.6
unknown	947	11.0	933	15.8	581	10.1	247	14.0
Chemotherapy
no	4,708	54.5	3,280	55.5	3,466	60.4	1,435	81.4
yes	2,790	32.3	1,891	32.0	1,658	28.9	44	2.5
unknown	1,141	13.2	741	12.5	613	10.7	284	16.1
Hormone therapy
no	4,535	52.5	4,793	81.1	4,769	83.1	923	52.4
yes	3,094	35.8	15	0.3	62	1.1	646	36.6
unknown	1,010	11.7	1,104	18.7	906	15.8	194	11.0
Number of consultations
0	424	4.9	361	6.1	223	3.9	95	5.4
1–2	2,083	24.1	1,321	22.3	1,098	19.1	326	18.5
3–5	2,487	28.8	1,565	26.5	1,498	26.1	479	27.2
6–10	2,161	25.0	1,598	27.0	1,586	27.6	510	28.9
>10	1,484	17.2	1,067	18.0	1,332	23.2	353	20.0
median (IQR)	5 (2–8)		5 (2–9)		6 (3–10)		5 (3–9)